Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.
|Articles|August 31, 2020
New practice risks post COVID-19
Author(s)Lindsey Carr, Editor
Although everyone is eager to return to normal, it is important that it is done safely.
Advertisement
Reopening decisions are happening across the country, and it is important to consider certain facets to ensure a safe opening for providers and patients.
In a recent interview with Karin Torpey Bashaw, Vice President of Patient Safety and Risk Management with The Doctors Company, Medical Economics discusses how physicians can prepare to reopen and manage risks in the new normal.
Advertisement
Related to this article
Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.
In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.
Jessica Shepherd, MD, MBA, FACOG, joins Missed & Dismissed to discuss why perimenopause is overlooked and how disparities shape who gets care.
Get caught up with Contemporary OB/GYN's latest coverage from The Menopause Society Annual Meeting in San Diego, California.
Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.
Susan Reed, MD, on the MsFLASH network's pooled findings, including nonhormonal therapies comparable to low-dose estradiol and CBT for sleep.
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Missed & Dismissed: From perimenopause to menopause, the transition medicine keeps missing
2
Safety Monitoring and Dosing for NK3 Antagonists in Menopause VMS
3
Multi-society framework ties cardiovascular risk to female life stages
4
Rhonda Voskuhl, MD, on estriol for cognitive symptoms of menopause
5